Allogeneic stem cell transplantation as initial salvage for patients with acute myeloid leukemia refractory to high-dose cytarabine-based induction chemotherapy.
about
Improvements in the early death rate among 9380 patients with acute myeloid leukemia after initial therapy: A SEER database analysisAllogeneic hematopoietic cell transplantation in patients with AML not achieving remission: potentially curative therapy.Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia.Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target.Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors.Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.Salvage therapy for acute chemorefractory leukemia by allogeneic stem cell transplantation: the Korean experience.Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission.An operational definition of primary refractory acute myeloid leukemia allowing early identification of patients who may benefit from allogeneic stem cell transplantation.Prognostic Significance of Residual Acute Myeloid Leukemia in Bone Marrow Samples Taken Prior to Allogeneic Hematopoietic Cell Transplantation.Multicentre survey to explore current survival of patients with acute myeloid leukaemia who failed induction chemotherapy.Treatment of relapsed/refractory acute myeloid leukaemia in adults.Similar outcome of allogeneic stem cell transplantation after myeloablative and sequential conditioning regimen in patients with refractory or relapsed acute myeloid leukemia: A study from the Société Francophone de Greffe de Moelle et de Thérapie CRemissions after third induction chemotherapy for primary non-responders with acute myeloid leukemia (AML) are uncommon and short-lived.Allogeneic stem cell transplantation for refractory acute myeloid leukemia in pediatric patients: the UK experience.Active acute leukaemia: should transplant be offered to all patients?
P2860
Q27336142-08A1ACE3-5F46-4659-8017-3158DE2EC450Q30399209-9AF72EEE-B8CA-4DF5-95AF-17F1D6239B72Q33830964-FCA66C15-44B6-487D-A49C-335216AAA95DQ35546759-F61E5E08-E6EC-4256-9839-983EB979C037Q35561304-7775B44B-A807-4774-B64E-C3D47923E357Q36557537-658C405E-B51B-4822-9912-D917CE7F0B2EQ37624593-F8454B81-0803-4446-8FB4-4733E9BEC158Q38406744-BB60EEE6-A071-45B2-854E-B35620D71F24Q39002077-09D9C5BD-9585-4DBC-8530-70573174D6DFQ39475017-DE0BA305-11FB-4F40-BD76-4BA53EDB12F9Q40370775-666A91C3-CEB9-45CF-896F-2C436B61FF26Q40725017-C3E1BE9C-F183-4D83-990D-0B14D2747F30Q47741553-551E3508-8CFB-42C7-A7CF-96D6925C690CQ48144263-C16EBB6C-A31D-41A0-9E10-D0E40BCEEDB1Q48305045-246D0C1A-C8E2-4B82-B856-221B1D484459Q52904223-16EE56B2-BDF3-449E-8C97-6210F2A0FD52Q54052781-B7E8986A-0936-4833-A62B-FB1EBEAD0FCD
P2860
Allogeneic stem cell transplantation as initial salvage for patients with acute myeloid leukemia refractory to high-dose cytarabine-based induction chemotherapy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Allogeneic stem cell transplan ...... -based induction chemotherapy.
@en
Allogeneic stem cell transplan ...... -based induction chemotherapy.
@nl
type
label
Allogeneic stem cell transplan ...... -based induction chemotherapy.
@en
Allogeneic stem cell transplan ...... -based induction chemotherapy.
@nl
prefLabel
Allogeneic stem cell transplan ...... -based induction chemotherapy.
@en
Allogeneic stem cell transplan ...... -based induction chemotherapy.
@nl
P2093
P2860
P50
P356
P1476
Allogeneic stem cell transplan ...... -based induction chemotherapy.
@en
P2093
A Megan Cornelison
Betul Oran
Hady Ghanem
Issa Khouri
Marcos de Lima
Marylou Cardenas-Turanzas
Michael Mathisen
Naval Daver
Richard Champlin
Stefan Ciurea
P2860
P304
P356
10.1002/AJH.23655
P50
P577
2014-03-07T00:00:00Z